Valuation: Terumo Corporation

Market Cap 3,355B 21.1B 18.56B 17.5B 15.97B 29.86B 2,026B 30.09B 210B 81.38B 1,031B 79.24B 77.52B P/E 2027 *
17.6x
P/E 2028 * 17.4x
Enterprise Value 3,401B 21.39B 18.82B 17.74B 16.18B 30.27B 2,054B 30.5B 213B 82.49B 1,045B 80.32B 78.58B EV / Sales 2027 *
2.7x
EV / Sales 2028 * 2.48x
Free-Float
97.34%
Yield 2027 *
1.62%
Yield 2028 * 1.76%
1 day+0.97%
1 week+2.61%
Current month-8.72%
1 month-11.55%
3 months+4.70%
6 months+9.64%
Current year+1.17%
1 week 2,230
Extreme 2230
2,303
1 month 2,194.5
Extreme 2194.5
2,619
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%+2.61%-4.31%+12.02% 21.1B
-2.34%-1.13%-24.51%+2.98% 175B
-0.88%-4.59%-7.55%+10.27% 113B
-0.77%+0.15%+0.49%+66.64% 59.13B
-1.80%-1.19%-3.67%-32.42% 48.82B
+1.49%+3.89%+13.73%+52.30% 48.69B
-0.30%-0.52%+29.59%-0.03% 33.01B
+1.05%+7.91% - - 30.41B
-0.60%+1.91%+43.73%+0.29% 26.29B
-0.28%+8.73%+23.44%-5.03% 23.87B
Average +0.17%+1.40%+7.88%+11.89% 57.94B
Weighted average by Cap. +0.36%-0.28%-3.70%+12.25%

Financials

2027 *2028 *
Net sales 1,261B 7.93B 6.97B 6.57B 6B 11.22B 761B 11.31B 78.9B 30.57B 387B 29.77B 29.12B 1,342B 8.44B 7.42B 7B 6.38B 11.94B 810B 12.03B 83.97B 32.54B 412B 31.68B 31B
Net income 191B 1.2B 1.05B 994M 907M 1.7B 115B 1.71B 11.92B 4.62B 58.55B 4.5B 4.4B 193B 1.21B 1.07B 1.01B 917M 1.72B 116B 1.73B 12.07B 4.68B 59.24B 4.55B 4.45B
Net Debt 45.99B 289M 254M 240M 219M 409M 27.77B 412M 2.88B 1.12B 14.13B 1.09B 1.06B -26.39B -166M -146M -138M -126M -235M -15.94B -237M -1.65B -640M -8.11B -623M -610M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
25/09/26 JPY 2,296.50 +0.97% 5,424,500
24/09/26 JPY 2,274.50 +1.63% 5,366,500
18/09/26 JPY 2,238.00 -2.33% 6,326,500
17/09/26 JPY 2,291.50 +2.12% 3,177,500
16/09/26 JPY 2,244.00 +0.07% 2,879,300
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,274.50JPY
Average target price
3,110.00JPY
Spread / Average Target
+36.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock